The Column Group (TCG) is a science-driven venture capital firm that makes significant financial and operational commitments to build early stage drug discovery companies based on their unique scientific platforms and potential to deliver multiple breakthrough therapeutics.
We believe our approaches to capital funding are uniquely flexible to give companies the leverage they need to advance their business goals and set new standards for the healthcare industry.
Osage University Partners (OUP) is a venture capital fund that invests exclusively in startups that are commercializing university research.
Our mission is simple – to help entrepreneurs build great companies. For more than 30 years, we have partnered with entrepreneurs, who, like us, define “greatness” as having a major positive impact on industries, customers and employees, while providing superior returns to investors.
Back to Top